PDT opportunities in oncology practice

M. L. Gelfond

doi:10.1117/12.640040

7 December 2006 PDT opportunities in oncology practice

M. L. Gelfond

Proceedings Volume 5973, Current Research on Laser Use in Oncology: 2000-2004; 597309 (2006) https://doi.org/10.1117/12.640040
Event: Current Research on Laser Use in Oncology: 2000-2004, 2004, Moscow, Russian Federation

Abstract

The results of novel photosensitizer Photoditazine clinical trials have demonstrated high clinical potential of the drug in the PDT of 53 patients with malignant tumors. The drug has advantageous spectral, physico-chemical and energetic characteristics in comparison to currently used Russian and foreign photosensitizers.

Citation Download Citation

M. L. Gelfond "PDT opportunities in oncology practice", Proc. SPIE 5973, Current Research on Laser Use in Oncology: 2000-2004, 597309 (7 December 2006); https://doi.org/10.1117/12.640040

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available